首页> 外文期刊>中国药理学报:英文版 >Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza)
【24h】

Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza)

机译:不同商品原料药和丹参制剂中四种活性成分的含量

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To detect the contents of four active components of Salvia miltiorrhiza in various commercially available danshen crude drugs and preparations. METHODS: Commercially available danshen crude drugs from different sources, as well as danshen pills and intravenous injection preparations containing danshen alone or in combination with other herbs were collected. The composition of these danshen samples was analyzed using HPLC. Specifically,the amounts of magnesium tanshinoate B (MTB), danshensu, isotanshinone ⅡA, and cryptotanshinone were determined.In some of these samples, the content of MTB was further confirmed by liquid chromatography-tandem mass spectrometer (LC-MS)/MS method. RESULTS: There were great variations in the amount of the four active ingredients in the commercially available danshen crude drugs and drug preparations in this study. The amount of MTB was the highest among the four components measured in the crude drugs. However, the amounts of MTB in all danshen preparations were much lower than those in crude drugs. The 2 lipophilic components, isotanshinone ⅡA and cryptotanshinone, were very low or not detectable in both injection and oral preparations. CONCLUSION:MTB can be used to standardize the various forms of danshen crude drugs and drug preparations from different sources. In view of the variation in the amounts of MTB and other components, improvement in the production methods of danshen preparations is essential to ensure consistent amount of its active ingredients and reproducible pharmacological actions.
机译:目的:检测各种市售丹参粗药物和制剂的丹参四种活性成分的含量。方法:从不同来源市市售的丹参粗药物,以及丹参药物和含有丹参的静脉注射制剂单独或与其他草药组合。使用HPLC分析这些Danshen样品的组成。具体而言,确定了丹参镁B(MTB),Danshensu,isotanshinoneⅡa和Cryptotalshinone的量。在这些样品中的一些,通过液相色谱 - 串联质谱仪(LC-MS)/ MS方法进一步证实MTB的含量。结果:本研究中市售丹参粗药物和药物制剂的四种活性成分的量存在很大的变化。在粗药物中测量的四种成分中,MTB的量是最高的。然而,所有Danshen制剂中的MTB的量远低于粗药物的MTB。在注射和口服制剂中,2种亲脂质组分,异甘油ⅡA和Cryptotalshinone非常低或不可检测。结论:MTB可用于标准化不同来源的各种形式的丹参粗药物和药物制剂。鉴于MTB和其他组分的量的变化,丹参制剂的生产方法的改善对于确保其一致的其活性成分和可重复的药理作用至关重要。

著录项

  • 来源
    《中国药理学报:英文版》 |2002年第12期|1163-1168|共6页
  • 作者单位

    Shanghai Xu Hui District Central Hospital, 966 Huai Hai Zhong Road, Shanghai 200031;

    Shanghai Xu Hui District Central Hospital, 966 Huai Hai Zhong Road, Shanghai 200031;

    Shanghai Xu Hui District Central Hospital, 966 Huai Hai Zhong Road, Shanghai 200031;

    Department of Pharmacology, Faculty of Medicine, University of Hong Kong, 21 Sassoon Road, Hong Kong, China;

    Department of Pharmacology, Faculty of Medicine, University of Hong Kong, 21 Sassoon Road, Hong Kong, China;

    Department of Pharmacology, Faculty of Medicine, University of Hong Kong, 21 Sassoon Road, Hong Kong, China;

    State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 294 Tai Yuan Road, Shanghai 200031, China;

  • 收录信息 北京大学中文核心期刊目录(北大核心);中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 药理学;
  • 关键词

    Salvia miltiorrhiza; magnesium tanshinoate B (MTB); high pressure liquid chromatography;

    机译:丹参;丹参酸镁B(MTB);高压液相色谱;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号